Literature DB >> 21478191

Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor β signalling.

Hisataka Sabe1.   

Abstract

Contrary to the long believed hypothesis, it is now evident that breast cancer cells can disseminate from the early phases of the oncogenesis; and that such early disseminated cells sometimes survive at the sites of dissemination and may outgrow after a long latency of years and decades. For cancer cells to leave their origin, they must at least transiently loosen their adhesion with adjacent epithelial cells and stroma, and become motile while avoiding anoikis. Such processes resemble epithelial-mesenchymal transdifferentiation (EMT), which normally takes place in situations such as embryogenesis and wound healing. Interestingly, the occurrence of an EMT-like process in breast cancer cells has been implicated in the generation of cancer stem-like cells, in which TGFβ1 signalling often plays core roles. Here, I discuss the current knowledge regarding cancerous EMT and its signalling pathways with the aim to consider the possible mechanisms of early dissemination, and also the generation of cancer stem-like cells in mammary tumour.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478191     DOI: 10.1093/jb/mvr044

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  23 in total

Review 1.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

2.  Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Authors:  Guoying Yu; Jose D Herazo-Maya; Tomoko Nukui; Marjorie Romkes; Anil Parwani; Brenda M Juan-Guardela; Jennifer Robertson; Jack Gauldie; Jill M Siegfried; Naftali Kaminski; Daniel J Kass
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

3.  Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.

Authors:  Ashwani Khurana; Deok Jung-Beom; Xiaoping He; Sung-Hoon Kim; Robert C Busby; Laura Lorenzon; Massimo Villa; Alfonso Baldi; Julian Molina; Matthew P Goetz; Viji Shridhar
Journal:  Clin Exp Metastasis       Date:  2013-02-15       Impact factor: 5.150

4.  Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells.

Authors:  Reem Eldawud; Alixandra Wagner; Chenbo Dong; Neha Gupta; Yon Rojanasakul; George O'Doherty; Todd A Stueckle; Cerasela Zoica Dinu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-07-15       Impact factor: 3.770

5.  Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.

Authors:  Junjun Liu; Xiaosong Chen; Toby Ward; Mark Pegram; Kunwei Shen
Journal:  Tumour Biol       Date:  2016-01-26

Review 6.  Pharmacological targets of breast cancer stem cells: a review.

Authors:  Sai Kiran S S Pindiprolu; Praveen T Krishnamurthy; Pavan Kumar Chintamaneni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-23       Impact factor: 3.000

7.  EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Authors:  Alexandria M Haslehurst; Madhuri Koti; Moyez Dharsee; Paulo Nuin; Ken Evans; Joseph Geraci; Timothy Childs; Jian Chen; Jieran Li; Johanne Weberpals; Scott Davey; Jeremy Squire; Paul C Park; Harriet Feilotter
Journal:  BMC Cancer       Date:  2012-03-19       Impact factor: 4.430

8.  Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy.

Authors:  Rumiko Kinoshita; Jin-Min Nam; Yoichi M Ito; Kanako C Hatanaka; Ari Hashimoto; Haruka Handa; Yutaro Otsuka; Shigeru Hashimoto; Yasuhito Onodera; Mitsuchika Hosoda; Shunsuke Onodera; Shinichi Shimizu; Shinya Tanaka; Hiroki Shirato; Mishie Tanino; Hisataka Sabe
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

9.  Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis.

Authors:  Nicolas Malaquin; Chantal Vercamer; Fatima Bouali; Sébastien Martien; Emeric Deruy; Nicolas Wernert; Maggy Chwastyniak; Florence Pinet; Corinne Abbadie; Albin Pourtier
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

10.  TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1.

Authors:  Erina Takai; Mitsutoshi Tsukimoto; Shuji Kojima
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.